Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 13, 2012Transplant International

Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

VAVincent AudardInsermNKNassim KamarUniversité Claude Bernard Lyon 1DSDil SahaliInserm

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Audard et al. (2012) studied this question.

synapsesocial.com/papers/6aa00633ba893741b69ca427https://doi.org/10.1111/j.1432-2277.2012.01462.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1INCIDENCE, TREATMENT, AND OUTCOME OF RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS POSTTRANSPLANTATION IN 42 ALLOGRAFTS IN CHILDREN1991 · 143 citations
  2. 2Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action2006 · 630 citations
  3. 3Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports2007 · 59 citations
  4. 4Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation2009 · 164 citations